Los Angeles Angels settles lawsuit with family of late pitcher Tyler Skaggs over fatal overdose

Skaggs Death Trial-Key Moments FILE - In this June 29, 2019, file photo, Los Angeles Angels starting pitcher Tyler Skaggs throws to an Oakland Athletics batter during a baseball game in Anaheim, Calif. (AP Photo/Marcio Jose Sanchez, File) (Copyright 2019 The Associated Press. All rights reserved.) (Marcio Jose Sanchez/AP)

SANTA ANA, Calif. (AP) — The Los Angeles Angels on Friday settled a lawsuit over the drug overdose death of pitcher Tyler Skaggs.

The decision to settle was reached after a two-month civil trial in Southern California over whether the Angels should be held responsible for Skaggs’ 2019 death after he snorted a fentanyl-laced pill provided by the team’s communications director, Eric Kay.

Skaggs’ widow, Carli, and his parents filed a lawsuit alleging the MLB team knew or should have known Kay was a drug addict and dealing painkillers to players. The team contended officials didn’t know Skaggs was taking drugs and would have sought him help if they did.

Jurors began deliberating earlier this week.

Orange County Superior Court Judge H. Shaina Colover thanked jurors for their diligence. “That is why this matter was able to be resolved today,” she said, before releasing them.

Six years ago, the 27-year-old left-handed pitcher was found dead in the suburban Dallas hotel room where he was staying as the Angels were supposed to open a four-game series against the Texas Rangers. A coroner’s report said the player choked to death on his vomit, and a toxic mix of alcohol, fentanyl and oxycodone was found in his system.

Kay, a longtime Angels employee, was convicted in 2022 of providing Skaggs with a counterfeit oxycodone pill laced with fentanyl and sentenced to 22 years in prison. His criminal trial in Texas included testimony from five MLB players who said they received oxycodone from Kay at various times from 2017 to 2019.

In California, MLB players including outfielder Mike Trout, Angels president John Carpino, and Skaggs’ and Kay’s relatives testified during the trial in a Santa Ana courtroom. Witnesses for the plaintiffs described how Kay was acting erratic at the stadium and found with multiple plastic bags filled with pills at his home and later hospitalized for a drug overdose. They also recounted how Kay got players massage appointments, tee times and even prescription medication, and was paid by players for stunts like taking a fastball to the leg.

Angels attorneys pointed out that Skaggs was hooked on painkillers before he signed with the Angels in 2013. They said Skaggs got his teammates into taking pills and got Kay to provide them, but kept it secret out of concern it could jeopardize their MLB careers. Had team officials known Kay was dealing drugs, or Skaggs was taking them, they would have done something, the lawyers said.

Witnesses also sparred during the case over how much money Skaggs would have made as a pitcher had he lived. Experts for the plaintiffs said he could have reeled in between $91 million and $101 million, while the Angels put the figure at no more than $32 million.

Skaggs had been a regular in the Angels’ starting rotation since late 2016 and struggled with injuries repeatedly during that time. He previously played for the Arizona Diamondbacks.

After Skaggs’ death, the MLB reached a deal with the players association to start testing for opioids and to refer those who test positive to the treatment board.

Before the judge announced the settlement Friday, jurors had remained behind closed doors after lawyers for both sides had gone to speak with Colover.

Late Wednesday, jurors had sent out a note asking whether they “get to decide the punitive damage amount,” saying there is no field for it on the verdict form. The judge said she would send a note replying that if they decide there should be punitive damages, they would decide how much at a later time.

The jury did not work on Thursday and resumed deliberations Friday morning.

Copyright 2025 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed without permission.

About The Author